Company Information

    Inhibrx was founded on January 2017. The company is based in La Jolla, CA, USA . The number of employees in Inhibrx is less than 100. Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

    Here is how Inhibrx describes itself: "Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Inhibrx has received 2 rounds of venture funding. The total funding amount is around $43.6M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Inhibrx - Blog

                          • Hello world!

                          • Welcome to WordPress. This is your first post. Edit or delete it, then start writing!The post Hello world! appeared first on Inhibrx.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *